National Research Corp Stock Performance
| NRC Stock | USD 14.83 0.24 1.64% |
The company secures a Beta (Market Risk) of 0.51, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, National Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding National Research is expected to be smaller as well. At this point, National Research Corp has a negative expected return of -0.24%. Please make sure to verify National Research's kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if National Research Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days National Research Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| National Research dividend paid on 10th of January 2025 | 01/10/2025 |
| Begin Period Cash Flow | 25 M |
National |
National Research Relative Risk vs. Return Landscape
If you would invest 1,756 in National Research Corp on December 17, 2024 and sell it today you would lose (273.00) from holding National Research Corp or give up 15.55% of portfolio value over 90 days. National Research Corp is generating negative expected returns assuming volatility of 2.6336% on return distribution over 90 days investment horizon. In other words, 23% of stocks are less volatile than National, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
National Research Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Research's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National Research Corp, and traders can use it to determine the average amount a National Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0918
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NRC |
Estimated Market Risk
| 2.63 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average National Research is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Research by adding National Research to a well-diversified portfolio.
National Research Fundamentals Growth
National Stock prices reflect investors' perceptions of the future prospects and financial health of National Research, and National Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.
| Return On Equity | 0.62 | ||||
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 400.77 M | ||||
| Shares Outstanding | 23.08 M | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 10.94 X | ||||
| Price To Sales | 2.39 X | ||||
| Revenue | 148.58 M | ||||
| EBITDA | 45.98 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 38.96 M | ||||
| Debt To Equity | 0.37 % | ||||
| Book Value Per Share | 1.35 X | ||||
| Cash Flow From Operations | 38.11 M | ||||
| Earnings Per Share | 1.04 X | ||||
| Total Asset | 122.44 M | ||||
| Retained Earnings | (30.53 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
About National Research Performance
By analyzing National Research's fundamental ratios, stakeholders can gain valuable insights into National Research's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if National Research has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if National Research has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. National Research operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 511 people.Things to note about National Research Corp performance evaluation
Checking the ongoing alerts about National Research for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National Research Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| National Research generated a negative expected return over the last 90 days | |
| National Research has a poor financial position based on the latest SEC disclosures | |
| About 38.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing National Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Research's stock is overvalued or undervalued compared to its peers.
- Examining National Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National Research's stock. These opinions can provide insight into National Research's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for National Stock analysis
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |